Counterpressure Maneuvers in Postural Orthostatic Tachycardia Syndrome
Launched by MEDICAL UNIVERSITY INNSBRUCK · Apr 10, 2025
Trial Information
Current as of May 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help people with Postural Orthostatic Tachycardia Syndrome (POTS), a condition that makes it hard for some individuals to stand up without feeling dizzy or experiencing a rapid heartbeat. Over a period of 14 days, participants will learn and practice specific exercises called counterpressure maneuvers (CPM) that aim to improve their symptoms. The trial will compare the effects of these maneuvers with standard care practices to see if they can help reduce symptoms, fatigue, and improve the overall quality of life for those affected by POTS.
To participate, individuals need to be diagnosed with POTS and be between 18 and 80 years old. They should be stable on their medications and able to stand for at least two minutes. Throughout the study, participants will receive guidance on how to perform these maneuvers safely, and they will be monitored closely. Those in the treatment group will attend additional training sessions to learn the CPM techniques while their heart rate and blood pressure are monitored. Participants can expect several visits over the course of the study, including both in-person and phone check-ins. This study aims to find ways to better manage POTS symptoms and improve daily living for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • POTS diagnosis
- • 18 to 80 years of age at time of consent
- • stable medication in the seven days prior to the baseline visit
- • able to provide written informed consent
- Exclusion Criteria:
- • participation in other interventional trials
- • pregnant or breastfeeding females
- • on treatment with vasoactive medications including medications for heart rate control
- • acute infections at the time of enrolment or in the two weeks before
- • acute pain
- • surgery in the last three months
- • inability or contraindication for performing hip and knee flexion, hip adduction or squatting
- • inability to stand for at least two minutes
- • Any other cardiological, internal, psychiatric or neurological condition, which may prevent engagement in the sturdy procedures in the judgement of the investigator
About Medical University Innsbruck
The Medical University of Innsbruck is a leading academic institution dedicated to advancing healthcare through innovative research and clinical excellence. Situated in the heart of the Austrian Alps, it combines a rich tradition of medical education with cutting-edge scientific inquiry. As a prominent sponsor of clinical trials, the university focuses on a broad spectrum of medical fields, emphasizing the translation of research findings into practical applications for patient care. With a commitment to ethical standards and rigorous methodologies, the Medical University of Innsbruck strives to enhance treatment options and improve health outcomes globally through its collaborative efforts in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Innsbruck, Tirol, Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported